1. Home
  2. FOXX vs NEPH Comparison

FOXX vs NEPH Comparison

Compare FOXX & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

HOLD

Current Price

$5.15

Market Cap

34.0M

Sector

N/A

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$2.89

Market Cap

31.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXX
NEPH
Founded
2017
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0M
31.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
FOXX
NEPH
Price
$5.15
$2.89
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
9.0K
46.7K
Earning Date
05-14-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.11
Revenue
N/A
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
N/A
$27.09
Revenue Growth
N/A
32.67
52 Week Low
$1.71
$1.78
52 Week High
$8.70
$6.42

Technical Indicators

Market Signals
Indicator
FOXX
NEPH
Relative Strength Index (RSI) 61.58 33.67
Support Level $4.90 N/A
Resistance Level $5.42 $3.21
Average True Range (ATR) 0.37 0.20
MACD 0.10 -0.01
Stochastic Oscillator 76.57 4.99

Price Performance

Historical Comparison
FOXX
NEPH

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: